Abstract:Background: The HLA-B*58:01 allele is associated with allopurinol-induced severe cutaneous adverse drug reactions (sCADR) in certain geographic regions, but the diversity of the correlation is large. In addition, the currently available HLA-B*58:01 testing methods are too laborious for use in routine clinical detection. The objective of this study was to develop a new, convenient method for the detection of HLA-B*58:01 and to investigate the association of HLA-B*58: 01 with allopurinol-induced sCADR in a Han Chinese population.Methods: A new method combining sequence-specific primers (SSP) and TaqMan probe amplification was developed in this study and was used to detect the HLA-B*58:01 in 48 allopurinol-induced sCADR, 133 allopurinol-tolerant, and 280 healthy individuals. The accuracy, sensitivity, and specificity were assessed by a commercial PCR-SSP HLA-B typing kit. The low limit of detection was detected by serial dilution of an HLA-B*58:01-positive DNA template.Results: The new method successfully identified HLAB*58: 01 in thousands of HLA-B alleles, and the results for 344 DNA samples were perfectly concordant with the results of the commercial PCR-SSP HLA-B kit. The analytical sensitivity is 100% and the specificity is over 99%. The low limit of detection of this assay is 100 pg DNA, which was 10 times more sensitive than the commercial PCR-SSP kit. HLA-B*58:01 was present in 93.8% of the patients with sCADR, 7.5% of the allopurinol-tolerant patients, and 12.1% of the healthy controls. The frequency of HLAB* 58: 01 was significantly higher in the sCADR group than in the control group (p < 0.0001). However, there was no significant difference between the allopurinol-tolerant and control groups (p = 0.1547).Conclusions: HLA-B*58:01 has a strong association with allopurinol-induced sCADR in Han Chinese. The newly developed method is reliable for HLA-B*58:01 detection prior to allopurinol therapy.

Rapid and Reliable Genotyping of HLA-B*58:01 in Four Chinese Populations Using a Single-Tube Duplex Real-Time PCR Assay.

Rapid and Reliable Genotyping Ofhla-B*57:01In Four Chinese Populations Using a Single-Tube Duplex Real-Time Polymerase Chain Reaction Assay

Rapid and Reliable Screening of HLA-B*15:02 in Four Chinese Populations Using Single-Tube Multiplex Real-Time PCR Assay

Rapid and Reliable Screening of HLA-B*15:02 in Four Chinese Populations Using Single-Tube Multiplex Real-Time PCR Assay.

A Multiplex Allele-Specific Real-Time Polymerase Chain Reaction Assay for Hla-B*13:01 Genotyping in Four Chinese Populations

Development of a rapid and reliable single-tube multiplex real-time PCR method for HLA-A*24:02 genotyping.

Rs144012689 is a Highly Specific Representative Marker of HLA-B*15:02 in the Chinese Population

A single-tube multiplex real-time PCR for <i>HLA-B*38:02</i> genotype by detecting highly specific SNPs

[An Investigation of the Polymorphism of HLA Class II Alleles in the Han Population in Hubei Province of China].

Detection of HLA-B*58:01 with TaqMan Assay and Its Association with Allopurinol-Induced Scadr

Rapid detection of HLA-B * 58∶01 gene based on multiplex melting curve analysis for the monitoring of adverse drug reaction caused by allopurinol

Clinical Evaluation of a Substitute of HLA-B*58:01 in Different Chinese Ethnic Groups.

Rapid and Reliable Genotyping of HLA-B*27 in the Chinese Han Population Using a Duplex Real-Time TaqMan PCR Assay

Development of an ARMS Multiplex Real-Time PCR Assay for the Detection of HLA-B*13:01 Genotype by Detecting Highly Specific SNPs

Development of an ARMS Multiplex Real-Time PCR Assay for the Detection of HLA-B*13:01 Genotype by Detecting Highly Specific SNPs.

Hla-B*58:01 Allele is Associated with Augmented Risk for Both Mild and Severe Cutaneous Adverse Reactions Induced by Allopurinol in Han Chinese

Genotyping Hla-B*5801 for Allopurinol-Induced Severe Cutaneous Adverse Reactions: an Accurate and Prompt Method

Single-tube multiplex real-time PCR assay for rapid and reliable detection of HLA-A*31:01 allele.

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies

Rs9263726 is a Specific Genetic Marker for Allopurinol-Induced Severe Cutaneous Adverse Reactions in Chinese Patients.

Analysis of DNA Polymorphism at HLA-A Locus by PCR Amplification with Sequence Specific Oligonucleotide Probe in Chinese Han and Uygur Populations.